More languages
More actions
Added fraudulent marketing cases. |
mNo edit summary |
||
| Line 42: | Line 42: | ||
}}</ref> | }}</ref> | ||
Pfizer bribed the U.S government for $1 billion to resolve allegations under the False Claims Act of illegal promotion of the drugs: Bextra, Geodon, Zyvox, and Lyrica.<ref name='DoJ Healthcare Fraud Entry' /> | Pfizer bribed the U.S government for $1 billion to resolve allegations under the False Claims Act of illegal promotion of the drugs: Bextra, Geodon, Zyvox, and Lyrica; and illegal bribery of hospital to promote these drugs.<ref name='DoJ Healthcare Fraud Entry' /> | ||
==References== | ==References== | ||
<references /> | <references /> | ||
Revision as of 14:55, 15 September 2022
Pfizer Inc. | |
|---|---|
 | |
| Industry |
|
| Key people | Albert Bourla (CEO) |
| Revenue | + $81.29 billion[1] |
| Net income | + $21.98 billion[1] |
| Website | |
| pfizer.com | |
[1] | |
Pfizer Inc. is a global pharmaceutical corporation.
Violations
Fraudulent Marketing
On September 2, 2009, Pfizer was sued for $2.3 billion by the U.S government for fraudulent marketing of multiple products.[2]
Pfizer bribed the U.S government for $1 billion to resolve allegations under the False Claims Act of illegal promotion of the drugs: Bextra, Geodon, Zyvox, and Lyrica; and illegal bribery of hospital to promote these drugs.[2]
References
- ↑ 1.0 1.1 1.2 Pfizer Inc. 2021 Form 10-K Annual Report. Pfizer Inc..
- ↑ 2.0 2.1 Office of Public Affairs - Department of Justice. Justice Department Announces Largest Health Care Fraud Settlement in Its History.